Annie Poupard
Joseph Fourier University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Annie Poupard.
European Journal of Neuroscience | 2000
François Windels; Nicolas Bruet; Annie Poupard; Nadia Urbain; Guy Chouvet; Claude Feuerstein; Marc Savasta
High frequency stimulation (130 Hz) of the subthalamic nucleus has dramatic beneficial motor effects in severe parkinsonian patients. However, the mechanisms underlying these clinical results remain obscure. The objective of the present work was to study the neurochemical changes induced in rats by high frequency stimulation of the subthalamic nucleus by using intracerebral microdialysis within its target structures. Our results show that high frequency stimulation of the subthalamic nucleus induces a significant increase of extracellular glutamate levels in the ipsilateral globus pallidus and substantia nigra while GABA was augmented only in the substantia nigra. These data suggest that functional effects induced by high frequency stimulation of the subthalamic nucleus might imply distal mechanisms involving the synaptic relationships with the subthalamic efferences. They question the current view that the direct inhibition of the subthalamic neurons is induced by high frequency stimulation.
Journal of Neuroscience Research | 2003
François Windels; Nicolas Bruet; Annie Poupard; Claude Feuerstein; Anne Bertrand; Marc Savasta
High‐frequency stimulation (HFS) of the subthalamic nucleus (STN) proves to be an efficient treatment for alleviating motor symptoms in Parkinsons disease (PD). However, the mechanisms of HFS underlying these clinical effects remain unknown. Using intracerebral microdialysis, we previously reported that HFS induces, in normal rats, a significant increase of extracellular glutamate (Glu) in the globus pallidus (GP in rats or GPe in primates) and the substantia nigra pars reticulata (SNr), whereas γ‐aminobutyric acid (GABA) was increased only in the SNr. Bradykinesia can be improved by STN stimulation in a frequency‐dependent manner, a plateau being reached around 130 Hz. The aim of the present study was to determine whether neurochemical changes are also frequency dependent. Electrical STN stimulation was applied at various frequencies (10, 60, 130, and 350 Hz) in normal rats. The results show that, for Glu, the amplitude of increase detected in GP and SNr is maximal at 130 Hz and is maintained at 350 Hz. No modifications of GABA were observed in GP whatever the frequency applied, whereas, in SNr, GABA increased from 60 to 350 Hz. Our results provide new neurochemical data implicating STN target structures in deep‐brain‐stimulation mechanisms.
The Journal of Neuroscience | 2005
François Windels; Carole Carcenac; Annie Poupard; Marc Savasta
High-frequency stimulation of the subthalamic nucleus (HFS-STN) is an effective treatment for alleviating the motor symptoms of parkinsonian patients. However, the neurochemical basis of its effects remains unknown. We showed previously that 1 h of HFS-STN in normal rats increases extracellular glutamate (Glu) level in the output nuclei of the STN, the globus pallidus (GP), and the substantia nigra pars reticulata (SNr), consistent with an increase in the activity of STN neurons. HFS-STN also increases GABA levels in the SNr, but the origin of this increase is unclear. We investigated the effectiveness of HFS-STN for improving Parkinsons disease symptoms, using intracerebral microdialysis to determine the extracellular Glu and GABA levels of the GP and SNr in response to HFS-STN in anesthetized hemiparkinsonian rats [6-hydroxydopamine lesion of the substantia nigra pars compacta (SNc)]. Basal levels of Glu and GABA in the GP and SNr were significantly higher in hemiparkinsonian than in intact rats. HFS-STN did not affect extracellular Glu level in the SNr of hemiparkinsonian rats but doubled the level of GABA. Ibotenic acid lesion of the GP abolished the increase in GABA levels in the SNr induced by HFS-STN in SNc-lesioned rats. These results provide neurochemical confirmation of the hyperactivity of the STN after dopaminergic denervation and suggest that the therapeutic effects of HFS-STN may result partly from the stimulation of pallidonigral fibers, thereby revealing a potential role for pallidal GABA in the inhibition of basal ganglial output structures during HFS-STN.
The Journal of Neuroscience | 2006
Sabrina Boulet; Emilie Lacombe; Carole Carcenac; Claude Feuerstein; Véronique Sgambato-Faure; Annie Poupard; Marc Savasta
The neurobiological mechanisms by which high-frequency stimulation of the subthalamic nucleus (STN–HFS) alleviates the motor symptoms of Parkinsons disease (PD) remain unclear. In this study, we analyzed the effects of STN–HFS on motor behavior in intact or hemiparkinsonian rats (6-hydroxydopamine lesion of the substantia nigra pars compacta) and investigated the correlation between these effects and extracellular glutamate (Glu) and GABA levels, assessed by intracerebral microdialysis in the substantia nigra pars reticulata (SNr). STN–HFS at an intensity corresponding to the threshold inducing contralateral forelimb dyskinesia, increased Glu levels in the SNr of both intact and hemiparkinsonian rats. In contrast, STN–HFS at half this intensity did not affect Glu levels in the SNr in intact or hemiparkinsonian rats but increased GABA levels in hemiparkinsonian rats only. STN–HFS-induced forelimb dyskinesia was blocked by microinjection of the Glu receptor antagonist kynurenate into the SNr and facilitated by microinjection of a mixture of the Glu receptor agonists AMPA and NMDA into the SNr. These new neurochemical data suggest that STN–HFS-induced forelimb dyskinesia is mediated by glutamate, probably via the direct activation of STN axons, shedding light on the mechanisms of STN–HFS in PD.
The Journal of Neuroscience | 2008
Sabrina Boulet; Stéphanie Mounayar; Annie Poupard; Anne Bertrand; Caroline Jan; Mathias Pessiglione; Etienne C. Hirsch; Claude Feuerstein; Chantal François; Jean Féger; Marc Savasta; Léon Tremblay
Parkinsons disease (PD) patients express motor symptoms only after 60–80% striatal dopamine (DA) depletion. The presymptomatic phase of the disease may be sustained by biochemical modifications within the striatum. We used an appropriate specific 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkey model (Mounayar et al., 2007) to study the compensatory mechanisms operating in recovery from PD motor symptoms. We assessed the levels of DA and its metabolites (DOPAC, homovanillic acid), GABA, glutamate (Glu), serotonin (5-HT) and its metabolite (5HIAA) by repeated intracerebral microdialysis in awake animals before exposure to MPTP during full expression of the motor symptoms induced by MPTP and after recovery from these symptoms. Measurements were obtained from two functionally and anatomically different striatal areas: the associative-limbic territory and sensorimotor territory. Animals with motor symptoms displayed an extremely large decrease in levels of DA and its metabolites and an increase in Glu and GABA levels, as reported by other studies. However, we show here for the first time that serotonin levels increased in these animals. We found that increases in DA levels in the sensorimotor and/or associative-limbic territory and high levels of 5-HT and of its metabolite, 5HIAA, were associated with recovery from motor symptoms in this model. Determining whether similar changes in DA and 5-HT levels are involved in the compensatory mechanisms delaying the appearance of motor symptoms in the early stages of PD might make it possible to develop new treatment strategies for the disease.
7th Triennial Meeting of the International-Basal-Ganglia-Society | 2002
Marc Savasta; François Windels; Nicolas Bruet; Anne Bertrand; Annie Poupard
The subthalamic nucleus (STN) which contains glutamatergic neurons (Smith and Parent, 1988) has come under focus in Parkinson’s disease (PD) from recent advances in the understanding of the functional organization of the basal ganglia in normal and pathological conditions. Based on this organization, normal movements would depend on an equilibrium between the activity of two output pathways from the neostriatum: a “direct” output to the internal segment of the globus pallidus (GPi)/substantia nigra pars reticulata (SNr) and an “indirect” output projecting via the external segment of the globus pallidus (GPe) and the STN (Albin et al., 1989; Alexander and Crutcher, 1989; DeLong, 1990). It was proposed that, in PD, the STN may become overactive as a result of disinhibition via the GPe in the indirect pathway, and suggested that the equilibrium might be restored by lesion or other manipulations of STN (DeLong, 1990).
Journal of Neuropathology and Experimental Neurology | 2001
Nicolas Bruet; François Windels; Anne Bertrand; Claude Feuerstein; Annie Poupard; Marc Savasta
Journal of Neuropathology and Experimental Neurology | 2003
Nicolas Bruet; François Windels; Carole Carcenac; Claude Feuerstein; Anne Bertrand; Annie Poupard; Marc Savasta
Proceedings of the National Academy of Sciences of the United States of America | 2005
Jean-Claude Platel; Sylvie Boisseau; Alain Dupuis; Jacques Brocard; Annie Poupard; Marc Savasta; Michel Villaz; Mireille Albrieux
Archive | 2005
Nicolas Maurice; Jean-Michel Deniau; Bertrand Degos; François Windels; Carole Carcenac; Annie Poupard; Marc Savasta